ArticleEuropean journal of medical research2025
Performance of the Primary Osteoporosis Screening Tool (POST) in osteoporosis screening: a cross-sectional study in China.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectivesThis study aimed to evaluate the efficacy of the Primary Osteoporosis Screening Tool (POST) in identifying osteoporosis among Chinese adults aged 50 years and older.
methodsThis retrospective cross-sectional study consecutively included patients from the University-Town Hospital of Chongqing Medical University. Osteoporosis was defined based on the T-scores of femoral neck bone mineral density (BMD) or lumbar spine BMD by dual-energy X-ray absorptiometry examinations. The POST scores were computed according to the subject information on age, sex, and weight. In addition, the performance of the POST was assessed and compared with the Osteoporosis Self-assessment Tool for Asians (OSTA) by area under the receiver operating characteristic curve, net reclassification improvement (NRI), integrated discrimination improvement (IDI).
resultsA total of 2861 patients were included in the final analysis, of whom 78.43% were women, with a mean age of 65.67 ± 9.81 years. The POST exhibited superior performance compared to OSTA in osteoporosis screening, as evidenced by a higher area under curve, enhanced NRI/IDI metrics, and remarkable sensitivity. Subgroup analysis further highlighted the superior efficacy of POST in individuals aged 65 years and older. Additionally, sensitivity analysis confirmed that the POST maintained robust performance in identifying individuals with osteoporosis, even after the exclusion of underweight patients.
conclusionsThe POST has been shown to be an effective instrument for osteoporosis screening among Chinese adults. Nonetheless, this study has limitations including its single-center retrospective design and imbalanced gender distribution, which may affect generalizability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.